|
|
|
Insider
Information: |
Southwell David P |
Relationship: |
Chief Executive Office... |
City: |
Concord |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
224,579 |
|
Indirect Shares
|
114,774 |
|
|
Direct
Value |
$679,862 |
|
|
Indirect Value
|
$2,298,230 |
|
|
Total
Shares |
339,353 |
|
|
Total
Value |
$2,978,093 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Human Genome Sciences Inc |
HGSI |
Chief Financial Officer |
2012-07-30 |
0 |
2009-03-13 |
0 |
Premium* |
|
First Eagle Alternative Capital ... |
FCRD |
Director |
2010-12-06 |
38,500 |
2010-11-16 |
0 |
Premium* |
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-05-08 |
12,850 |
2024-05-08 |
1,650 |
Premium* |
|
Rocket Pharmaceuticals |
RCKT |
|
2024-05-02 |
1,660 |
2024-05-02 |
113,124 |
Premium* |
|
Tscan Therapeutics, Inc. |
TCRX |
Chief Executive Office... |
2022-05-18 |
171,569 |
2021-09-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HGSI |
Human Genome Sciences Inc |
Director |
|
2009-03-13 |
4 |
B |
$0.72 |
$52,341 |
D/D |
73,000 |
73,000 |
2.39 |
- |
|
HGSI |
Human Genome Sciences Inc |
David Southwell |
|
2010-04-12 |
4 |
A |
$32.86 |
$3,187 |
D/D |
97 |
73,097 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
David Southwell |
|
2010-06-01 |
4 |
OE |
$2.09 |
$101,731 |
D/D |
17,653 |
90,750 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
David Southwell |
|
2010-07-12 |
4 |
A |
$32.86 |
$2,793 |
D/D |
85 |
90,835 |
0 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-11-16 |
4 |
B |
$12.84 |
$110,706 |
D/D |
8,622 |
8,622 |
2.39 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-11-17 |
4 |
B |
$12.80 |
$70,324 |
D/D |
5,478 |
14,100 |
2.39 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-11-18 |
4 |
B |
$12.82 |
$146,365 |
D/D |
11,400 |
25,500 |
2.39 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-11-19 |
4 |
B |
$12.83 |
$6,406 |
D/D |
499 |
25,999 |
2.39 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-11-22 |
4/A |
B |
$12.82 |
$1,296 |
D/D |
101 |
26,100 |
2.31 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-11-22 |
4 |
S |
$12.82 |
$1,296 |
D/D |
(101) |
26,100 |
0 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-11-23 |
4 |
S |
$12.83 |
$1,283 |
D/D |
(100) |
26,200 |
0 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-11-23 |
4/A |
B |
$12.83 |
$1,283 |
D/D |
100 |
26,200 |
2.31 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-11-24 |
4 |
B |
$12.84 |
$2,568 |
D/D |
200 |
26,400 |
2.31 |
- |
|
FCRD |
First Eagle Alternative C... |
Director |
|
2010-12-06 |
4 |
B |
$12.97 |
$157,277 |
D/D |
12,100 |
38,500 |
2.39 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2012-07-30 |
4 |
D |
$14.25 |
$1,294,399 |
D/D |
(90,835) |
0 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Director |
|
2013-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,238 |
|
- |
|
PTCT |
PTC Therapeutics, Inc. |
Director |
|
2014-03-21 |
4 |
AS |
$30.54 |
$71,666 |
D/D |
(2,317) |
10,921 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Director |
|
2015-03-23 |
4 |
AS |
$68.99 |
$159,957 |
D/D |
(2,317) |
8,604 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Director |
|
2015-07-06 |
4 |
AS |
$47.50 |
$1,121,694 |
D/D |
(23,604) |
0 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Director |
|
2015-07-06 |
4 |
OE |
$10.85 |
$162,750 |
D/D |
15,000 |
23,604 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
President and CEO |
|
2017-01-06 |
4 |
B |
$1.75 |
$105,000 |
D/D |
60,000 |
62,765 |
2.81 |
- |
|
RCKT |
Rocket Pharmaceuticals |
Director |
|
2018-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,875 |
38,535 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
|
|
2018-11-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
153,125 |
191,660 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
|
|
2018-12-06 |
4 |
S |
$15.15 |
$800,056 |
D/D |
(52,809) |
138,851 |
0 |
- |
|
RCKT |
Rocket Pharmaceuticals |
|
|
2018-12-07 |
4 |
S |
$14.91 |
$73,402 |
D/D |
(4,923) |
133,928 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|